














Cervical cancer is the second most com-
mon neoplasia among women worldwide. The 
disease burden is higher in the developing 
world, and it has been estimated that, in the 
northern region of Brazil, it is the most im-
portant cause of cancer-related deaths among 
women (4.6 per 100,000 women), with an 
incidence of 16.75 cases per 100,000 women 
for the year 2006.1 Specifi cally for the State of 
Acre, in the Brazilian Amazon region and one of 
the smallest states in Brazil, with only 670,000 
residents, the mortality rate due to cervical 
cancer was 4.02 and there were 14.53 new cases 
for each 100,000 women in 2002.1,2 There is a 
considerable likelihood, however, that these al-
ready high fi gures were greatly underestimated. 
It is suspected that many cases are inadequately 
recorded, because the population cannot access 
health services and their social and economic 
circumstances are very unfavorable.
Cervical cancer screening programs are 
based on the detection of pre-invasive lesions, 
i.e. cervical intraepithelial neoplasia (CIN). 
Cervical cytological tests (Papanicolaou tests, 
or Pap smears) are the primary screening tool 
used in Brazil. However, in order to be effec-
tive, cytology-based screening programs neces-
sitate a complex and expensive infrastructure: 
primary healthcare units to systematically 
collect the smears, trained professionals, labo-
ratories for slide processing and reading and, 
fi nally, professionals capable of dealing with 
the abnormalities that may be detected.
OBJECTIVE
The purpose of the present study was 
to estimate the changes in the incidence of 
pre-invasive and invasive cervical neoplasia 
that a possible improvement in access to 
health services would cause, in a small and 




This study was carried out in the city of 
Cruzeiro do Sul, which is located in the ex-
treme west of the Brazilian Amazon basin, in 
the State of Acre. It has been estimated that, 
in 2001, the municipality had 67,441 inhabi-
tants,3 52% of them living in rural areas. The 
city is accessible mainly by river or air trans-
portation, because during the rainy season the 
main roads to the city remain unserviceable. 
Illiteracy is very common: approximately 40% 
of the population cannot read or even sign 
their own names.2 Economic development is 
negatively affected by the region’s geographical 
position, in the middle of the Amazon forest, 
and by several concurrent social problems.
Community-level intervention
Women were recruited through local 
advertisements, by radio broadcasting and 
oral communication; the latter was per-
formed by the investigators themselves. To 
be eligible to enter the study, women had to: 
a) provide informed consent by signing (or 
placing their fi ngerprints on) the informed 
consent form (which was read out by one 
of the investigators when the women were 
unable to read it themselves); b) have a cervix 
uteri; c) be outside of the bleeding period of 
the menstrual cycle; d) have not had sexual 
intercourse or applied vaginal creams over the 
three days prior to consultations. Women in 
this last condition were advised to schedule 
a new appointment in a few days thereafter. 
Women were excluded if they: a) had under-
taken a Pap test during the last year prior to 
this consultation; b) had undertaken cervical 
cauterization, biopsy or conization during the 
last year prior to this consultation; c) were 
pregnant; d) had had cervical neoplasia (any 
type) in the past.
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CONTEXT AND OBJECTIVE: In the northern region 
of Brazil, cervical cancer is the most important 
cause of cancer-related deaths among women. 
There is considerable likelihood, however, that 
offi cial incidence and mortality fi gures are greatly 
underestimated. The aim of this study was to 
estimate the repercussions from improvement 
in cervical cancer screening programs on the 
incidence of pre-invasive and invasive cervical 
lesions in a municipality in this region. 
DESIGN AND SETTING: This was a quasi-experi-
mental study that assessed process dimensions 
relevant to the program objectives. The study 
comprised a sample of 2,226 women seen at 
primary healthcare units in Cruzeiro do Sul, a 
small city in the Brazilian Amazon region, from 
April 2003 to July 2004.
METHODS: Women were recruited through local 
radio advertisements and by oral communication 
from the investigators. The women answered a 
structured questionnaire and underwent pelvic 
examination, which included Papanicolaou (Pap) 
smears and naked-eye inspection of the cervix 
after applying diluted acetic acid. Women with 
positive Pap smears or abnormal gynecological 
examination were referred for colposcopy and 
possible biopsy, diathermic large loop excision 
of the transformation zone or conization. 
RESULTS: The results obtained were compared with 
historical offi cial data retrieved from the Brazilian 
Ministry of Health’s database. Intervention resulted 
in a 40% increase in positive Pap smears and 
detection of cancer was nine times higher than 
had been observed in routine screening. 
CONCLUSIONS: Detection of pre-invasive and 
invasive cervical lesions in the intervention group 
was remarkably higher than among women seen 
during routine screening. 
KEY WORDS: Cervix uteri. Neoplasms. Diagno-
sis. Ambulatory care. Vaginal smears.
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A total of 2,226 women were enrolled, 
and consultations were carried out in the 
primary healthcare units of Cruzeiro do Sul, 
from April 2003 to July 2004. In addition to 
the consultations performed for the purposes 
of this study, another 3,780 routine Pap tests 
were carried out in Cruzeiro do Sul while the 
study was underway.
Consultation routine
After signing the informed consent 
form, the women responded to a structured 
questionnaire and were subjected to pelvic 
examination, with inspection of the cervix and 
collection of samples for the Pap test. As a fi nal 
step, 3.0% diluted acetic acid was applied to 
the cervix, and the cervix was re-examined using 
the naked eye. Abnormal results from the cervi-
cal inspection or Pap test prompted referral for 
colposcopy, with possible biopsy or diathermic 
excision of the transformation zone, depending 
on the characteristics of the lesion.
Pap smear
Pap smears were taken using an Ayre spatula 
and endocervical brush. They were fi xed in 95% 
ethanol and stained using the modifi ed Papanico-
laou method. The fi nal cytological diagnosis was 
obtained using the Bethesda System,4 and the 
results were classifi ed as normal/infl ammatory, 
atypical squamous cells (ASC), atypical glandular 
cells (AGC), low-grade squamous intraepithelial 
lesion (LSIL), high-grade squamous intraepi-
thelial neoplasia (HSIL) or suggestive of cancer. 
The cytological slides from smears collected 
from patients enrolled to this study were read 
by an experienced cytopathologist, based at the 
cytology laboratory of Universidade Estadual de 
Campinas. On the other hand, patients screened 
normally, within the offi cial program, had their 
Pap tests performed by local laboratories in the 
State of Acre. For statistical purposes, normal/in-
fl ammatory results were categorized as negative, 
and ASC, LSIL or HSIL as positive.
Histology
Biopsy and conization specimens were 
fi xed in 10% phosphate-buffered formalin, em-
bedded in paraffi n, and stained with hematoxy-
lin and eosin (HE). Biopsies were analyzed accor-
ding to the World Health Organization (WHO) 
criteria5 and classifi ed as negative, CIN 1, CIN 2, 
CIN 3 or invasive squamous carcinoma.
Statistical methods
Box plot representations of the mean, me-
dian and standard deviations of age at diagnosis 
for each pre-neoplastic or neoplastic lesion were 
produced. The performance estimators, or the 
Figure 1. Age-related distribution of fi nal diagnoses of cervical intraepithelial neoplasia 








fi rmed disease was even higher among women 
with HSIL, since 81.1% of them had CIN 2 
or worse. All the women with Pap smears sug-
gestive of cancer did indeed have high-grade 
disease (Table 1). The majority (69.4%) of the 
CIN cases occurred in women below 40 years 
of age, and disease severity increased in parallel 
with age (Figure 1). 
The proportion of cytology abnormalities 
in this series was 40% higher (ratio: 1.40) 
than what has been offi cially reported for the 
city of Cruzeiro do Sul.3 However, during the 
intervention period of the study, the number of 
HSIL or worse Pap tests was four times higher 
(ratio: 4.1) than the offi cial historical fi gures, 
and the proportion of cancer cases detected in 
the population was nine times higher (ratio: 
9.3) than what was observed from routine 
screening (Table 2).
DISCUSSION
The primary purpose of this study was to 
evaluate the consequences of a community-
based intervention for the screening of women 
who had not had a Pap test over the preceding 
12 months, in a remote municipality in the 
Amazon region. In this intervention study, 
in comparison with the offi cial historical data 
and routine screening in Cruzeiro do Sul, a 
remarkably higher number of abnormal Pap 
tests were found and many more cases of cancer 
were detected. It should be noted, however, that 
invasive cancer detection rates generally exceed 
the cancer incidence rates in the population, 
percentages of positive screening tests across dif-
ferent categorical strata, were compared with his-
torical data retrieved from the Brazilian Ministry 
of Health’s database.1 The cancer detection rate 
was calculated per 1,000 women screened. 
RESULTS
The patients’ ages ranged from 20 to 83 
years (mean: 39.6 years). Of the 2,226 Pap 
smears collected, 2,106 (94.6%) were classi-
fi ed as negative. The most frequent Pap ab-
normality was ASC (1.9%), followed by HSIL 
(1.8%), LSIL (0.7%), AGC (0.6%), squamous 
cells carcinoma (0.3%) and adenocarcinoma 
in situ (0.09%).
Cervical inspection revealed abnormalities 
in 21.2% of the women, and 541 women were 
examined by means of colposcopy. Abnormal 
fi ndings from colposcopy were found in 26% 
of the women that had undertaken the exami-
nation, and 55.8% of these women also had a 
positive Pap test (data not shown).
Visually detectable lesions were found in 
a few women with negative cytology: six cases 
of CIN 1, ten of CIN 2 or 3 and one case of 
cancer. The majority (78.6%) of the women 
with AGC were found to be free of histologi-
cally-confi rmed disease, and the same occurred 
in 63.6% of the women with ASC. Three 
(6.8%) of the women with ASC had cancer, 
and 13 (29.6%) of these were diagnosed with 
CIN 2 or 3. Among women with LSIL, six 
(37.5%) were diagnosed with CIN 2 or 3. The 
proportion of women with histologically-con-
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because some cancers would remain asymp-
tomatic in the absence of screening. In the 
present series, the cancer detection rate (4.49 
cases per 1,000 women screened) was 30 times 
higher than the offi cially estimated incidence 
of the disease in Cruzeiro do Sul (14.53 per 
100,000 women).3
In countries where the female population 
is screened appropriately, it has been estimated 
that less than 1% of Pap smears should harbor 
a cytological abnormality.4,6 In the present 
study, 5.4% of the Pap smears were considered 
to be abnormal. This can be attributed to 
inadequate previous screening (if any), and 
to the criterion of only including women who 
had not had a Pap test during the 12 months 
prior to enrollment. In addition, the personnel 
involved in the study were well-trained and 
performed rigorous quality control at all stages 
of the screening, from recruiting the women 
to their treatment. 
In alignment with the high rate of Pap 
abnormalities found in this study, 21.2% of the 
women also had abnormalities in their cervix that 
were visible to the naked eye. In India and some 
African nations, investigators have analyzed the 
possible role of visual inspection of the cervix 
with acetic acid (VIA), alone or in combination 
with Pap smears, as a screening tool. In one of 
these studies, reporting on 2,754 women, 29.4% 
of the subjects aged 35-39 years old had abnor-
mal fi ndings from VIA, while this rate decreased 
to 23.4% in women aged 50-65 years.7-9
High sensitivity is probably the most desir-
able feature in a screening test. The sensitivity of 
Pap smears, when the test is performed under 
ideal conditions (i.e. adequate collection, slides 
immediately fi xed and experienced cytologists) 
barely exceeds 70%.10,11 On the other hand, it 
is also desirable that the number of false-posi-
tive results be reduced to a minimum, thereby 
avoiding unnecessary referrals for colposcopy. It 
has been well established that colposcopy places 
a heavy burden on healthcare systems, because 
it can only be performed by trained physicians, 
thus restricting its usage in underdeveloped 
regions. In the present study, abnormal col-
poscopy fi ndings were present in 55.8% of the 
women who had altered Pap smears. However, 
it has to be mentioned that, in contrast with the 
expected fi gures, the number of women with 
high-grade disease was exceptionally high. The 
correlation between Pap smear abnormalities 
and the real presence of cervical disease is not 
very favorable for low-grade cytological fi nd-
ings. In the ASCUS-LSIL Triage Study (ALTS), 
only 15% of women with ASC were diagnosed 
with signifi cant histological lesions, and 50% of 
those with LSIL had abnormal cervical patterns 
visible via colposcopy.9
It is unreasonable to suppose that the cervi-
cal cancer screening defi ciencies in the remote 
and impoverished regions of Brazil could be 
resolved in the short term. Cytology-based 
screening programs demand expensive and 
complex infrastructure. In addition, Pap smears 
do not yield results immediately, which is espe-
cially problematic in sparsely populated regions 
with severe transportation shortcomings, like 
most of the Brazilian Amazon region.
As reported and well discussed in previous 
Indian, African and even Brazilian reports, VIA 
might be an acceptable alternative to cytology 
in low-resource settings with high incidence of 
cervical neoplasia, considering the logistic and 
economic circumstances usually encountered 
in such regions. This is certainly the case in 
the geographic region where the present study 
was conducted. For instance, as advocated by 
Sankaranarayanan et al., VIA allows diagnosis 
and treatment of cervical abnormalities on a 
single occasion. This would clearly help over-
come one of the main problems in the Amazon 
region: the huge distances between settlements 
Table 1. Final diagnoses from the cytology results of 2,226 women screened for cervical cancer
Histology
Cytology
Neg AGC ASC LSIL HSIL In situ adeno-carcinoma
Invasive adeno-
carcinoma Total
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Neoplasia absent 2,089 (91.2) 11 (78.6) 28 (63.6) 7 (43.8) 7 (18.9) 0 0 2,142 (96.2)
CIN 1 6 (0.28) 0 0 3 (18.8) 0 0 0 9 (0.4)
CIN 2 3 (0.14) 0 4 (9.1) 4 (25.0) 4 (10.8) 0 0 15 (0.7)
CIN 3 7 (0.33) 3 (21.4) 9 (20.5) 2 (12.5) 24 (64.9) 0 3 (42.9) 48 (2.2)
In situ adenocarcinoma 0 0 0 0 1 (2.7) 1 (50.0) 0 2 (0.09)
Invasive squamous 
carcinoma 1 (0.05) 0 3 (6.8) 0 1 (2.7) 0 4 (57.1) 9 (0.4)
Invasive adenocarcinoma 0 0 0 0 0 1 (50.0) 0 1 (0.04)
Total 2,106 (100.0) 14 (100.0) 44 (100.0) 16 (100.0) 37 (100.0) 2 (100.0) 7 (100.0) 2,226 (100.0)
Neg = negative; AGC = atypical glandular cells; ASC = atypical squamous cells; LSIL = low-grade squamous intraepithelial lesion; HSIL = high-grade squamous intraepithelial neoplasia; 
CIN = cervical intraepithelial neoplasia.
Table 2. Screening performance estimators for cervical cancer  
Historical data1  (2001-2002) This study (2003-2004) Ratio
Number of tests in target population 2993 2226 ---
Percentage of screening tests with positive results 3.9 5.4 1.4
Percentage of screening tests positive for HSIL or cancer 0.5 2.1 4.1
• Percentage of screening tests positive for HSIL 0.5 1.7 3.5
• Percentage of screening tests positive for cancer 0.03 0.3 9.3
Cancer detection rate per 1,000 women screened (fi nal diagnosis) NA 4.49 ---
NA = not available; HSIL = high-grade squamous intraepithelial neoplasia.
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RESUMO
Impacto de uma intervenção comunitária na melhoria da cobertura de um programa de rastreamento para 
câncer do colo do útero na região amazônica brasileira
CONTEXTO E OBJETIVO: Na Região Norte do Brasil, o câncer do colo do útero é a mais importante causa 
de morte, por câncer, entre as mulheres. É muito provável, entretanto, que os dados ofi ciais referentes à 
incidência e à mortalidade estejam grosseiramente subestimados. O objetivo foi estimar as repercussões 
que a melhora dos programas de rastreamento possam exercer sobre a incidência de lesões pré-invasoras 
e invasoras do colo do útero em uma municipalidade da região Amazônica brasileira.
TIPO DE ESTUDO E LOCAL: Este estudo “quasi-experimental” avaliou dimensões processuais relevantes 
para os objetivos do programa de rastreamento. Foi incluída uma amostra de 2.226 mulheres, atendidas 
em unidades básicas de saúde de Cruzeiro do Sul, uma pequena cidade da Amazônia Brasileira, entre 
abril de 2003 e julho de 2004.
MÉTODOS: As mulheres foram recrutadas através de anúncio pelo rádio e por comunicação oral desempe-
nhada pelos próprios pesquisadores. Após assinarem o Termo de Consentimento Informado, responderam 
a um questionário estruturado e foram submetidas a exame pélvico, o que incluiu coleta e colpocitologia 
oncológica (CO) e inspeção da cérvice após aplicação de ácido acético diluído. Mulheres com CO posi-
tiva ou exame ginecológico anormal foram encaminhadas para colposcopia e eventual biópsia, excisão 
diatérmica da zona de transformação ou conização. 
RESULTADOS: Os resultados obtidos foram comparados a dados históricos ofi ciais referentes à cidade 
de Cruzeiro do Sul, recuperados do banco de dados do Ministério da Saúde do Brasil. Em comparação 
aos dados históricos, a intervenção resultou em um aumento de 40% na freqüência de CO positiva, e a 
detecção de câncer foi nove vezes superior àquela dos dados ofi ciais. 
CONCLUSÕES: A detecção de lesões cervicais pré-invasoras e invasoras no grupo que sofreu intervenção 
foi marcadamente superior à das mulheres atendidas pelo programa ofi cial de rastreamento. 
PALAVRAS-CHAVE: Colo uterino. Câncer. Diagnóstico. Assistência ambulatorial. Esfregaço vaginal.
and between primary healthcare units. VIA 
has also been reported to have an acceptable 
positive predictive value in populations that 
are highly affected by cervical disease, which 
is certainly the case in Cruzeiro do Sul.12-16 In 
the present study, the cervix of the patients 
was examined using acetic acid and the naked 
eye, and this increased the number of cervical 
abnormalities diagnosed by 25.5%. However, 
this examination should not be named VIA, 
because this procedure involves a standard 
routine, i.e. usage of 5% acetic acid and proper 
personnel training. On the other hand, there is 
an Atlas dedicated to VIA interpretation.17
CONCLUSIONS
The results from the present study allow the 
conclusion that, in the Brazilian Amazon region, 
it is very likely that the offi cial fi gures for the 
incidence and prevalence of cervical disease are 
underestimated. The large numbers of CIN and 
cancer cases that were detected might well refl ect 
the ineffective screening in the region, and prop-
erly planned and structured public interventions 
might increase cervical cancer detection rates in 
such underserved geographical areas. According 
to data gathered by other authors, VIA might 
be a highly acceptable option for the screening 
of cervical abnormalities among the female 
population in the Amazon region.
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